Report DescriptionAbout IMARC Group

International Market Analysis Research and Consulting Group is a leading adviser on management strategy and market research worldwide. We partner with clients in all regions and industry verticals to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, chemicals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

IMARC’s tailored approach combines unfathomable insight into the dynamics of companies and markets with close cooperation at all levels of the client organization. This ensures that our clients achieve unmatchable competitive advantage, build more proficient organizations, and secure lasting results.

Global Cancer/Tumor Profiling Market Research Report 2022-2027:

According to the latest report by IMARC Group, titled " Cancer/Tumor Profiling Market: Global Industry Trends, Share, Size, Growth, Opportunity and Fore cast 2022-2027

," the global cancer tumor profiling market reached a value of US$ 9.38 Billion in 2021.

Cancer/tumor profiling, or biomarker testing, is a process of identifying specific proteins, genes, gene mutations (changes), and other biomarkers in a tumor tissue sample. It assists in determining whether the pathways of a tumor match up with the available targeted therapies. It is also used for therapeutic decision-making, routine diagnostics, and personalized treatment plans and therapies based on the severity of the ailment and genomic build-up.

As a result, cancer/tumor profiling finds extensive applications in the discovery of biomarkers, research, personalized medicines, and the development of screening and diagnostic techniques.

Request for a PDF sample of this report: https://www.imarcgroup.com/cancer-tumor-profiling-market/requestsample

Global Cancer/Tumor Profiling Market Trends:

The market is primarily driven by the increasing prevalence of cancer across the globe. In addition, the growing inclination toward personalized medicine among the masses represents another major growthinducing factor. Besides this, governments of numerous countries are investing in cancer research to develop advanced techniques to reduce the time taken for the detection and identification of tumors. This, coupled with the increasing investments by pharmaceutical and biotechnology companies in research and development (R&D) activities for introducing novel therapies and new drug-designing techniques, is positively influencing the market growth.

Furthermore, recent advancements in molecular biology techniques, the rising number of clinical trials, the increasing adoption of immunoassay techniques, and the developing healthcare infrastructure across the globe are some of the other factors creating a positive market outlook across the globe.

Looking forward, IMARC Group expects the market to reach a value of US$ 18.22 Billion by 2027, exhibiting a CAGR of 11.20% during the forecast period (2022-2027).

View Report TOC, Figures and Tables: https://www.imarcgroup.com/cancer-tumor-profiling-market